Skip to main content

Peer Review reports

From: Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels

Original Submission
1 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
7 Apr 2021 Reviewed Reviewer Report
17 May 2021 Author responded Author comments - Shan Cheng
Resubmission - Version 4
17 May 2021 Submitted Manuscript version 4
25 May 2021 Author responded Author comments - Shan Cheng
Resubmission - Version 5
25 May 2021 Submitted Manuscript version 5
Publishing
9 Jun 2021 Editorially accepted
29 Jun 2021 Article published 10.1186/s12885-021-08495-z

You can find further information about peer review here.

Back to article page